CBD-infused candies, commonly known as gummies, have been recalled in Paris due to concerns of potential intoxication. The recall affects products sold in three stores in the capital city and is in effect until January 31, 2024. Consumers are advised to return the product to the point of purchase for an exchange.
The decision to recall the candies was prompted by an incident where a group of individuals experienced adverse effects after consuming the product. Seven individuals required hospitalization as a result of ingesting the CBD candies. Subsequent analysis of the recalled candies revealed the presence of THC, the psychoactive compound found in cannabis, as well as H4CBD, a derivative of CBD. Although the levels of these compounds did not exceed permissible thresholds, they were deemed potentially dangerous, particularly for individuals who are not regular consumers of CBD products.
The lack of specific usage recommendations for the gummies further underscores the potential risks associated with their consumption. Despite the minimal amounts of the substances ingested, they were considered too high in relation to the low weight of the candy, highlighting the dangers of consuming such products in both the short and long term.
Consumers are strongly advised to refrain from consuming these CBD-infused candies to avoid potential risks. The presence of THC and H4CBD within permissible limits points to the importance of closely monitoring and regulating the sale and consumption of CBD products to ensure consumer safety.
